Psilocybin for Anorexia Nervosa with Stephanie Knatz Peck, PhD
In this episode of the Psychedelic Medicine Podcast, Stephanie Knatz Peck, PhD joins to discuss the research on psilocybin for anorexia nervosa. Dr. S…
Managing Medical Risk in Patients Seeking Psilocybin Therapy with Reid Robison, MD, MBA
In this episode of the Psychedelic Medicine Podcast, Dr. Reid Robison joins to discuss managing medical risk in patients seeking psilocybin therapy. D…
CME/CE Psilocybin Course
Announcing Our First-Ever CME/CE Course: Managing Medical Risk in Patients Seeking Psilocybin Therapy Interested in Taking the Course? Click here to learn more and enroll! Visit Course Page *Register by completing this form. You’ll be emailed with a calendar invitation. Name First Email* Untitled Automatic Webinar Registration NameThis field is for validation purposes and should […]
The Psychedelic Medicine Association Journal Club March 2023
The Spring 2023 edition of the Psychedelic Medicine Association Journal Club *Register by completing this form. You’ll be emailed with a calendar invitation. Log In To Watch the Recording *Exclusive for members. Thursday, March 30th at 5 pm Pacific, 8 pm Eastern >> Log In To Watch the Recording >> Join us for the spring […]
Optimal Delivery of Psychedelic Experiences with Paul Thambi, MD
In this episode of the Psychedelic Medicine Podcast, Paul Thambi, MD joins to discuss insights on the optimal delivery of psychedelic experiences stem…
Psilocin vs. Psilocybin: Differences & Potential Clinical Uses with Josh Woolley, MD, PhD
In this episode of the Plant Medicine Podcast, Dr. Josh Woolley joins to discuss the differences between psilocin and psilocybin, and to share upcomin…
The Latest Research on Psilocybin for Depression with Matthew Johnson, PhD
In this episode of the Plant Medicine Podcast, Matt Johnson, PhD joins to discuss the latest research of psilocybin as a treatment for depression. Dr….
Psychedelics’ Ability to Help Heal Traumatic Brain Injury with Dr. Kate Pate
Dr. Kate Pate is a neurophysiologist who has been conducting research for 15 years in a variety of different areas, including neurotrauma, respiratory…
Microdosing Q&A with James Fadiman
James Fadiman, PhD, was a part of the first wave of pioneering psychedelic researchers in the 1960s in the US. He’s the co-founder of the Institute of…
How YOU Can Participate in The New Psilocybin Study from Unlimited Sciences and Johns Hopkins
Del Jolly is co-founder and director of Unlimited Sciences, a psychedelic research non-profit. He was the outreach director for the Decriminalize Denv…